Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
This study investigates the feasibility of a gait-retraining program for older adults with knee osteoarthritis. The study will enroll 40 participants, with 20 receiving a gait retraining intervention and 20 receiving a graded walking program without gait retraining.
Description: # of participants screened per month
Measure: Recruitment rate Time: through study completion, an average of 2 yearsDescription: # of participants enrolled per month
Measure: Enrollment rate Time: through study completion, an average of 2 yearsDescription: % participants that complete all study visits
Measure: Retention Time: through study completion, an average of 2 yearsDescription: Proportion of participants who withdraw or terminated by investigators and reasons why
Measure: Withdrawals/Terminated Time: through study completion, an average of 2 yearsDescription: Proportion of participants with AE/UP
Measure: Adverse events (AE)/Unanticipated problems (UP) Time: through study completion, an average of 2 yearsDescription: Slope of the most linear portion of the vertical ground reaction force curve, during early stance.
Measure: Vertical average loading rate Time: Change from baseline to conclusion of intervention, an average of 1-monthDescription: Maximum slope of the most vertical portion of the vertical ground reaction force curve between successive data points, during early stance.
Measure: Vertical instantaneous loading rate Time: Change from baseline to conclusion of intervention, an average of 1-monthDescription: WOMAC questionnaire, pain sub scale 0-20
Measure: Knee Pain with Activities Time: Change from baseline to conclusion of intervention, an average of 1-monthDescription: Visual analog scale, 0-100
Measure: Knee Pain Severity Time: Change from baseline to conclusion of intervention, an average of 1-monthDescription: Assessed using hand held algometer
Measure: Pressure pain threshold Time: Change from baseline to conclusion of intervention, an average of 1-monthAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports